Literature DB >> 3440648

Conservative treatment of tuberculosis of the thoracic and lumbar spine in adults and children.

M S Moon1, I Kim, Y K Woo, Y O Park.   

Abstract

We have treated 75 cases of spinal tuberculosis with chemotherapy as outpatients. The drugs used were INH, rifampicin and ethambutol for the 48 adults, and INH, rifampicin and PAS for the 27 children. No operations, apart from the evacuation of large abscesses, were carried out. Every patient was followed up for at least three years and the outcome was judged to be favourable in 95%. This is better than in some series in which radical surgery has been used. Although we recognize the advantages of operation in certain circumstances, we believe that our conservative regimen can be confidently recommended for use in less privileged countries, where adequate facilities for hospital treatment may not be available.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440648     DOI: 10.1007/BF00271307

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  26 in total

1.  TREATMENT FOR TUBERCULOSIS OF THE SPINE. ANTI-TUBERCULOSIS DRUGS IN CONJUNCTION WITH RADICAL OPERATION AND SHORT HOSPITALIZATION WITH NO ENFORCED RECUMBENCY OR IMMOBILIZATION.

Authors:  B PAUS
Journal:  Acta Orthop Scand Suppl       Date:  1964

2.  ANTERIOR APPROACHES IN THE DIAGNOSIS AND TREATMENT OF INFECTIONS OF THE VERTEBRAL BODIES.

Authors:  W H KIRKALDY-WILLIS; T G THOMAS
Journal:  J Bone Joint Surg Am       Date:  1965-01       Impact factor: 5.284

3.  Tuberculosis of the spine treated conservatively with chemotherapy: series of 72 patients collected 1949-1954 and followed to 1961.

Authors:  F H STEVENSON; C W MANNING
Journal:  Tubercle       Date:  1962-12

4.  The ambulant treatment of spinal tuberculosis.

Authors:  P G KONSTAM; A BLESOVSKY
Journal:  Br J Surg       Date:  1962-07       Impact factor: 6.939

5.  Fusion of the spine for tuberculosis in children; a long-range follow-up study.

Authors:  M CLEVELAND; D M BOSWORTH; J W FIELDING; P SMYRNIS
Journal:  J Bone Joint Surg Am       Date:  1958-01       Impact factor: 5.284

6.  Early results of treatment of spinal tuberculosis by triple drug therapy.

Authors:  S M Tull; S Kumar
Journal:  Clin Orthop Relat Res       Date:  1971 Nov-Dec       Impact factor: 4.176

7.  Radical surgical approach to spinal tuberculosis.

Authors:  S B Kohli
Journal:  J Bone Joint Surg Br       Date:  1967-11

8.  Five-year assessments of controlled trials of ambulatory treatment, debridement and anterior spinal fusion in the management of tuberculosis of the spine. Studies in Bulawayo (Rhodesia) and in Hong Kong. Sixth report of the Medical Research Council Working Party on Tuberculosis of the Spine.

Authors: 
Journal:  J Bone Joint Surg Br       Date:  1978-05

9.  A controlled trial of ambulant out-patient treatment and in-patient rest in bed in the management of tuberculosis of the spine in young Korean patients on standard chemotherapy a study in Masan, Korea. First report of the Medical Research Council Working Party on Tuberculosis of the Spine.

Authors: 
Journal:  J Bone Joint Surg Br       Date:  1973-11

10.  A 10-year assessment of controlled trials of inpatient and outpatient treatment and of plaster-of-Paris jackets for tuberculosis of the spine in children on standard chemotherapy. Studies in Masan and Pusan, Korea. Ninth report of the Medical Research Council Working Party on Tuberculosis of the Spine.

Authors: 
Journal:  J Bone Joint Surg Br       Date:  1985-01
View more
  28 in total

Review 1.  Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues.

Authors:  Chrysanthi L Skevaki; Dimitrios A Kafetzis
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

2.  Clinical, radiological and functional outcome of posterior-only three-column osteotomy in healed, post-tubercular kyphotic deformity: a minimum of 2-year follow-up.

Authors:  Bhavuk Garg; Tungish Bansal; Nishank Mehta; Dhruv Sharma
Journal:  Spine Deform       Date:  2021-05-12

3.  Surgical management of complex post-tuberculous kyphosis among African patients: clinical and radiographic outcomes for a consecutive series treated at a single institution in West Africa.

Authors:  Ali M Maziad; Owoicho Adogwa; Henry Ofori Duah; Kwadwo Poku Yankey; Derrick Nyantakyi Owusu; Arthur Sackeyfio; Mabel Adobea Owiredu; Tyler Wilps; Gerhard Ofori-Amankwah; Franklin Coleman; Harry Akoto; Irene Wulff; Oheneba Boachie-Adjei
Journal:  Spine Deform       Date:  2021-01-05

Review 4.  Historical aspects of Pott's disease (spinal tuberculosis) management.

Authors:  Surendar M Tuli
Journal:  Eur Spine J       Date:  2012-07-17       Impact factor: 3.134

Review 5.  Kyphotic deformity in spinal tuberculosis and its management.

Authors:  Shanmuganathan Rajasekaran
Journal:  Int Orthop       Date:  2012-01-11       Impact factor: 3.075

Review 6.  Modified pedicle subtraction osteotomies (mPSO) for thoracolumbar post-tubercular kyphosis in pediatric patients: retrospective clinical cases and review of the literature.

Authors:  Zhang Hong-Qi; Chen Yong; Huang Jia; Guo Chaofeng; Hu Xiongke
Journal:  Childs Nerv Syst       Date:  2015-05-08       Impact factor: 1.475

7.  Single-stage closing-opening wedge osteotomy of spine to correct severe post-tubercular kyphotic deformities of the spine: a 3-year follow-up of 17 patients.

Authors:  S Rajasekaran; Kamath Vijay; Ajoy Prasad Shetty
Journal:  Eur Spine J       Date:  2009-12-15       Impact factor: 3.134

8.  Posterior approach in thoracolumbar tuberculosis: a clinical and radiological review of 67 operated cases.

Authors:  Saurabh Rawall; Kapil Mohan; Abhay Nene
Journal:  Musculoskelet Surg       Date:  2012-12-15

Review 9.  Severe kyphotic deformity in tuberculosis of the spine.

Authors:  S M Tuli
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

Review 10.  Natural history of Pott's kyphosis.

Authors:  S Rajasekaran
Journal:  Eur Spine J       Date:  2012-05-15       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.